Tag:
elacytarabine
Latest Headlines
Latest Headlines
Clavis touts Phase II AML data
Oslo, Norway-based Clavis Pharma has announced positive results form a Phase II trial of elacytarabine (CP-4055), a drug for late-stage acute myeloid leukaemia (AML). Elacytarabine showed
